Age, Initial Central Retinal Thickness, and OCT Biomarkers Have an Influence on the Outcome of Diabetic Macular Edema Treated With Ranibizumab– Tri-center 12-Month Treat-and-Extend Study

Objective: We report the tri-center 1-year outcomes of a treat-and-extend (T&E) regimen in four-week intervals with ranibizumab for diabetic macular edema (DME).Methods: In this retrospective study, all eyes received 3 monthly loading injections of 0.5 mg ranibizumab, followed by a T&amp...

Full description

Bibliographic Details

Published in:	Frontiers in Medicine
Main Authors:	Chun-Ting Lai, Yi-Ting Hsieh, Chun-Ju Lin, Jia-Kang Wang, Chih-Ying Lin, Ning-Yi Hsia, Henry Bair, Huan-Sheng Chen, Chiung-Yi Chiu, Shao-Wei Weng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-05-01
Subjects:	age central retinal thickness diabetic macular edema OCT biomarkers ranibizumab treat-and-extend regimen 5
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2021.668107/full